Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Lung Neoplasms 4Carcinoma, Non-Small-Cell Lung 3Small Cell Lung Carcinoma 2Smoking 1Pulmonary Disease, Chronic Obstructive 1Precancerous Conditions 1

Interventions

X-Rays 2Standard of Care 2Bronchoscopy 2vilanterol 1perflutren 1Surgical Procedures, Operative 1Sulfur Hexafluoride 1Sulfonylurea Compounds 1Specimen Handling 1Sodium-Glucose Transporter 2 Inhibitors 1Singing 1Rehabilitation 1Pulmonary Surgical Procedures 1Iloprost 1Hematologic Tests 1Educational Status 1Drug Delivery Systems 1Dipeptidyl-Peptidase IV Inhibitors 1CIMAvax EGF 1Budesonide 1Bronchoalveolar Lavage 1Blood Specimen Collection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Pulmonary Disease, Chronic Obstructive × Budesonide × Thoracic × Clear all
NCT02504801 2015-07-22

Efficacy of Nebulized Pulmicort Respules in Primary Lung Cancer Patients With COPD

Xuanwu Hospital, Beijing

Phase 4 Unknown
73 enrolled
Thoracic

Lung Neoplasms, Pulmonary Disease, Chronic Obstructive

Data powered by HemOnc (CC BY 4.0) Colophon âš¡